This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus
Leggi →
Giugno 2024